Bayer Makes Offer to Acquire Monsanto
News May 19, 2016
The proposed combination would reinforce Bayer as a global innovation-driven Life Science company with leadership positions in its core segments, and would create a leading integrated agriculture business.
This statement follows Monsanto’s announcement earlier today regarding a proposal from Bayer. A further statement will be made as appropriate.
Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.READ MORE